Doximity Inc (NASDAQ:DOCS) stock is trading higher on Friday after the company reported third-quarter fiscal 2025 results that beat analysts’ expectations and upbeat guidance.
Doximity reported adjusted EPS of 45 cents, up from 29 cents a year ago and beating the consensus of 34 cents.
Sales increased 25% year-over-year to $168.6 million, beating the consensus of $152.82 million and management guidance of $152 million to $153 million.
Doximity offers a digital platform for U.S. medical professionals
“We’re proud to deliver another quarter of record engagement in Q3, with over 610,000 unique providers using our clinical workflow tools,” Doximity CEO Jeff Tangney said in a statement.
“Our AI tools grew the fastest last quarter, up 60% over the prior quarter, while our newsfeed surpassed more than one million unique providers.”
The company reported an adjusted EBITDA of $102.0 million, up 39% year over year, better than the management forecast of $83 million to $84 million. Net income jumped 57% to $75.2 million.
Guidance: For its fiscal fourth quarter, Doximity said it expects revenue of $132.5 million and $133.5 million, compared with analysts’ estimates of $123.84 million.
The company also raised its 2025 revenue guidance to $564.6 million—$565.6 million, up from the prior outlook of $535 million—$540 million and versus the consensus of $539.98 million.
Adjusted EBITDA is expected to be between $306.6 million and $307.6 million compared to prior guidance of $274 million to $279 million.
Analyst Reaction:
Price Action: DOCS stock is up 37% at $79.80 at last check Friday.
Read Next:
Photo: courtesy of Doximity
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。